This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Consejo Superior De Investigaciones Cientificas. Active years: 2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2015
Title: Ana Pérez Castillo: Innovator in Neurodegenerative Disease Treatment
Introduction
Ana Pérez Castillo is a prominent inventor based in Madrid, Spain. She has made significant contributions to the field of medicine, particularly in the treatment of neurodegenerative diseases. Her innovative work focuses on the development of new therapeutic compounds that can potentially improve the lives of those affected by conditions such as Parkinson's and Alzheimer's diseases.
Latest Patents
Ana holds a patent for the "Use of quinazoline derivatives for neurodegenerative diseases." This invention relates to a series of quinazoline-derived compounds that can be used to produce a medicament aimed at treating and preventing neurological and neurodegenerative diseases. The patent outlines a method for administering a therapeutically effective amount of these compounds to patients, showcasing her commitment to advancing medical science.
Career Highlights
Ana Pérez Castillo is affiliated with the Consejo Superior de Investigaciones Científicas, a leading research institution in Spain. Her work has garnered attention for its potential impact on public health, particularly in addressing the challenges posed by neurodegenerative diseases. With her innovative approach, she continues to push the boundaries of medical research.
Collaborations
Ana collaborates with esteemed colleagues, including Ana Martínez Gil and Carmen Gil Ayuso-Gontan. These partnerships enhance her research efforts and contribute to the development of effective treatments for neurodegenerative conditions.
Conclusion
Ana Pérez Castillo is a trailblazer in the field of neurodegenerative disease treatment, with her innovative patent highlighting the potential of quinazoline derivatives. Her work at the Consejo Superior de Investigaciones Científicas and collaborations with fellow researchers underscore her dedication to improving healthcare outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile